| Dr Anne Elizabeth Mattingly, MD | |
|
112 Hospital Ln Ste 100, Danville, IN 46122 | |
| (317) 745-3740 | |
| Not Available |
| Full Name | Dr Anne Elizabeth Mattingly |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 14 Years |
| Location | 112 Hospital Ln Ste 100, Danville, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174842595 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01076886A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Hancock Regional Hospital | Greenfield, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hancock Physician Network, Llc | 8325952633 | 107 |
| Hancock Regional Hospital | 1850205162 | 45 |
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
Scientists at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.
Dinah Jimenez assumed a world-class hospital would be better prepared than a chowder house to inform workers when they had been exposed to a deadly virus.
The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies - both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.
› Verified 7 days ago
| Entity Name | Hancock Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806470 PECOS PAC ID: 8325952633 Enrollment ID: O20040130000777 |
News Archive
Scientists at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.
Dinah Jimenez assumed a world-class hospital would be better prepared than a chowder house to inform workers when they had been exposed to a deadly virus.
The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies - both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.
› Verified 7 days ago
| Entity Name | Hancock Regional Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255418356 PECOS PAC ID: 1850205162 Enrollment ID: O20040401000258 |
News Archive
Scientists at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.
Dinah Jimenez assumed a world-class hospital would be better prepared than a chowder house to inform workers when they had been exposed to a deadly virus.
The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies - both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.
› Verified 7 days ago
| Entity Name | Hendricks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
Scientists at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.
Dinah Jimenez assumed a world-class hospital would be better prepared than a chowder house to inform workers when they had been exposed to a deadly virus.
The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies - both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne Elizabeth Mattingly, MD 1100 Southfield Dr, Ste 1370, Plainfield, IN 46168-4300 Ph: (317) 837-5570 | Dr Anne Elizabeth Mattingly, MD 112 Hospital Ln Ste 100, Danville, IN 46122 Ph: (317) 745-3740 |
News Archive
Scientists at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.
Dinah Jimenez assumed a world-class hospital would be better prepared than a chowder house to inform workers when they had been exposed to a deadly virus.
The Wall Street Journal reports on the challenges of calculating future income and health insurance subsidies - both of which will have an impact on the health law's new insurance marketplaces. Meanwhile, The Washington Post reports on how executive-branch and legislative-branch employees will have different experiences with the overhaul.
OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one recommending against approval of the daily pill Tarceva® (erlotinib) for first-line maintenance use in people with advanced or metastatic non-small cell lung cancer (NSCLC) whose cancer has not progressed (grown or spread) following first-line treatment with platinum-based chemotherapy.
› Verified 7 days ago
Dr. Monet Williams Bowling, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln Ste 100, Danville, IN 46122 Phone: 317-718-9000 Fax: 317-719-9010 | |
Dr. Michael J Pyle, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 E Main St, Danville, IN 46122 Phone: 317-745-4451 Fax: 317-718-6740 | |
Mindy M. Ho, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln Ste 100, Danville, IN 46122 Phone: 317-745-3740 Fax: 317-745-3816 | |
Dr. Kimberly A Kerr, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln, Suite 100, Danville, IN 46122 Phone: 317-745-3740 Fax: 317-745-3816 | |
Dr. Lemoyne Rheul Pringle, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 998 E Main St Ste 101, Danville, IN 46122 Phone: 317-745-8642 Fax: 317-745-8645 | |
P Daniel Read, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 112 Hospital Ln, Suite 100, Danville, IN 46122 Phone: 317-745-3740 Fax: 317-745-3816 |